Wellnex Life Limited Reports Strong Sales Growth: ASX WNX Analysis
Wellnex Life Limited (ASX:WNX) recently reported a significant increase in total sales for the first half of FY25. Impressively, their total sales soared to $11.94 million, a remarkable 112% growth from the same period in FY24 when it was $5.63 million.
A major factor contributing to this growth was the substantial increase in brand sales, which shot up by 182% to $8.47 million from $3.0 million year-on-year. The standout moment was in December 2024, with sales reaching $3.02 million, a staggering 1018% increase from December 2023’s $0.27 million.
Breaking down the revenue figures, we see some significant developments. In December, brand sales jumped to $2.0 million, marking a substantial 640% increase. Additionally, IP licensing revenues made a noteworthy contribution, totaling $1.02 million.
Looking at the revenue composition for the first half of FY25, we observe brand sales of $8.47 million, up from $3.0 million in the previous period. IP licensing revenues also saw strong growth, increasing by 64% from $2.12 million to $3.47 million.
The Board of Wellnex is confident about the company’s continued growth in the coming months of FY25. Their focus will be on expanding brand distribution and awareness, as well as enhancing IP licensing operations. It’s an exciting time for Wellnex as they look ahead to a promising future.
